NMRA financials
Neumora Therapeutics (NMRA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
NMRA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$241.16M | -$236.93M | -1.45 |
| 2024 | – | – | -$263.46M | -$243.79M | -1.53 |
| 2023 | – | – | -$252.10M | -$235.93M | -3.63 |
| 2022 | – | – | -$135.87M | -$130.90M | -4.81 |